Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus. [electronic resource]
Producer: 20170901Description: 1803-1809 p. digitalISSN:- 1527-3350
- Adult
- Aged
- Aminoisobutyric Acids
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Confidence Intervals
- Cyclopropanes
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Heterocyclic Compounds, 4 or More Rings -- administration & dosage
- Humans
- Lactams, Macrocyclic
- Leucine -- analogs & derivatives
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Prospective Studies
- Quinoxalines
- Ribavirin -- administration & dosage
- Severity of Illness Index
- Sofosbuvir -- administration & dosage
- Sulfonamides -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.